Niche women-owned CRO Target capitalizing on C3's women-owned, boutique CRO positioning to offer flexible staffing and customized study teams for small to mid-size clinical trials that require agility and cost efficiency.

Small scale leverage Sales approach should emphasize partnership for small organizations or niche programs where larger CROs offer limited flexibility, highlighting consistent teams, quality, and scalable resources within a lean operation.

Global tech stack Leverage existing tech usage such as WordPress, Microsoft 365 and standard web tools to propose integrated digital collaboration, secure data sharing, and streamlined communication with sponsors seeking modern, efficient virtual trial management.

Competitive positioning Differentiate from mega-CROs by promoting cost-effective, customized solutions and rapid onboarding with a stable core team, aligning with sponsors who value efficiency and personalized attention.

Revenue growth path Identify opportunities in early-phase to mid-sized trials and niche therapeutic areas where C3 can scale services without extensive headcount, presenting tiered engagement models and measurable ROI for potential clients.